Skip to content

    Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide
    AdaptogenPreclinical

    Ashwagandha Dosage Guide: Protocols, Calculator & Safety

    Everything you need to know about Ashwagandha dosing — protocols, safety, and where to buy.

    Dosage Calculator

    Calculate exact dosing for Ashwagandha.

    Dosing Protocols

    Beginner

    Beginner (Months 1–2): Evening dose for sleep and general stress support.

    Dose. Ashwagandha root extract (standardized to 5% withanolides minimum, preferably branded KSM-66) 300 mg in the evening with dinner.

    Product. KSM-66 is the most-studied extract and the single best first choice for a beginner. Specific products containing KSM-66 at 300–600 mg include: Jarrow Formulas Ashwagandha, NOW Foods Ashwagandha, Thorne Memoractiv (includes KSM-66 in a stack), Life Extension Optimized Ashwagandha, and many others. Alternative: Sensoril 125 mg evening if sleep is the primary goal. Cost: $15–25/month.

    Schedule. Evening with dinner, 300 mg once daily. The evening timing leverages ashwagandha's mild sedating effect to support sleep onset and relaxation wind-down.

    Monitoring. Baseline: brief subjective baseline of stress (1–10 scale), sleep quality (1–10 scale), and energy. Consider basic labs if you have reason: TSH and free T4 (ashwagandha modestly increases thyroid hormones), morning cortisol, fasting glucose. Recheck subjective measures at week 4 and week 8.

    Concurrent basics. Sleep hygiene: consistent bed/wake times, cool dark bedroom, no screens 30+ minutes before bed, caffeine cutoff after noon. Exercise: 2–3 resistance training sessions per week, 150 minutes moderate cardio per week. Diet: adequate protein (0.8–1 g/kg), Mediterranean-pattern vegetables and olive oil, limit ultra-processed food. Alcohol: moderate or eliminate if sleep is a primary concern (alcohol is the single worst commonly-used sleep disruptor).

    Expected outcomes at 4 weeks. Most users notice: improved sleep onset and maintenance, mild reduction in racing thoughts at bedtime, slight improvement in next-day energy, feeling less "wired." Some users report vivid dreams in the first 2 weeks. Subjective stress rating typically improves by 1–2 points on a 10-point scale.

    Expected outcomes at 8 weeks. More established benefits: consistent better sleep, improved daily stress tolerance, improved recovery from workouts (less soreness, quicker recovery), mild improvement in afternoon energy, better mood stability. Serum cortisol would typically show ~20% reduction if tested. Energy and stress metrics typically improved by 2–3 points on a 10-point scale.

    When to progress. Move to intermediate if: (a) current dose is well-tolerated and benefits are apparent, (b) you want to target additional effects (testosterone, muscle gains, cognitive support), (c) stress load has increased (new job, life transition, training increase) and you want deeper support, or (d) sleep quality is improved but daytime stress resilience still needs work.

    Standard

    Intermediate (Months 2–6): Divided dosing for broader daytime and evening support.

    Dose. KSM-66 300 mg BID (morning with breakfast + evening with dinner), total 600 mg/day. Alternative: KSM-66 600 mg evening once daily if morning dosing causes any sedation issues.

    Product. Continue with KSM-66 at scaled-up dose. Specific 600 mg/serving products: Jarrow Formulas Ashwagandha 300 mg (take two), Thorne Ashwagandha, NOW Foods Ashwagandha Extract, Life Extension Optimized Ashwagandha. Cost: $20–35/month.

    Schedule. 300 mg with breakfast; 300 mg with dinner. This distributes the withanolide exposure across the day for sustained HPA modulation. Alternative single-dose protocols use 600 mg evening — simpler but may have slightly different pharmacokinetic profile.

    Concurrent stack additions.

    • Magnesium glycinate 300–400 mg evening: sleep and muscle relaxation support.
    • L-theanine 200 mg as needed for acute stress or in the evening alongside ashwagandha.
    • Vitamin D3 2000–5000 IU/day (per 25-OH level): hormonal and immune support.
    • Omega-3 (EPA+DHA) 1000–2000 mg/day.
    • B-complex (especially B12, folate, B6): stress and methylation support.
    • Zinc 15–30 mg/day (if diet is low in zinc): testosterone cofactor.

    If focus on testosterone and strength.

    • Continue KSM-66 600 mg/day.
    • Add Tongkat Ali 200 mg/day (cycle 8 weeks on / 4 weeks off).
    • Add Zinc 25 mg/day + Vitamin D3 5000 IU/day + Boron 5 mg/day.
    • Creatine 5 g/day.
    • Progressive resistance training program, 3–4 sessions per week, focus on compound movements (squat, deadlift, bench press, row, overhead press).
    • Adequate protein (1.6–2.2 g/kg bodyweight for active adults).
    • Sleep 7–9 hours per night.
    • Lab testing at baseline and 12 weeks: testosterone (total and free), SHBG, estradiol (for ratio awareness), DHEA-S, LH/FSH.

    If focus on sleep.

    • Ashwagandha 600 mg evening once daily.
    • Magnesium glycinate 400 mg evening.
    • L-theanine 200 mg + glycine 3 g 30–60 minutes before bed.
    • Sleep hygiene rigor (temperature, darkness, consistent timing, digital curfew).
    • Consider CBT-I (cognitive behavioral therapy for insomnia) if clinical insomnia diagnosed.
    • Melatonin 0.3–1 mg 2–3 hours before bed if circadian component (time zone travel, shift work, delayed sleep phase).

    If focus on cognitive support.

    • KSM-66 300 mg BID.
    • Bacopa monnieri 300 mg/day standardized to 50% bacosides.
    • Lion's Mane mushroom 500 mg BID.
    • Citicoline 250 mg/day.
    • Omega-3 (DHA-dominant) 1500 mg/day.
    • Rhodiola 300 mg morning for acute cognitive support if needed.

    Monitoring. CMP including liver enzymes at 12 weeks (monitor for any rare hepatotoxicity signal). TSH, free T4, free T3 at 12 weeks if baseline done. Testosterone panel at 12 weeks if pursuing that indication. Subjective tracking continued.

    Expected outcomes at 12–24 weeks. Benefits typically stable and more deeply integrated. Sleep quality maintained or improved. Stress resilience noticeably improved — users often report being "less rattled" by stressors that previously would have produced significant anxiety or rumination. Testosterone elevation if being tracked: typically 10–20% increase over baseline in adult males starting with low-normal T. Strength gains in resistance trainers: meaningful improvements in 1RM and work capacity. Cognitive measures: modest improvements in memory, processing speed, and executive function if assessed.

    When to progress. Move to advanced protocol if: (a) pursuing maximum polyphenol, adaptogen, and recovery stack for longevity intent, (b) working with functional medicine or integrative physician on comprehensive protocol, or (c) specific high-demand context (elite athlete, high-stress executive, recovery from significant illness) warranting broader support.

    Advanced

    Advanced (Months 6+ or high-demand contexts): Comprehensive stress-recovery-longevity integration.

    Dose. KSM-66 300 mg BID + Sensoril 125 mg evening (for users wanting both root and root-plus-leaf spectrums), or KSM-66 600 mg BID (900 mg/day total at the upper clinical dose range). Adjust based on subjective response; there is no strong rationale to exceed 1000 mg/day standardized extract.

    Product. Multi-branded stack or consolidated products. Examples: Thorne Phytisone (adrenal complex including ashwagandha), Gaia Herbs Adrenal Health Daily Support, Life Extension Optimized Ashwagandha + Rhodiola combination, Pure Encapsulations Ashwagandha. Or purchase KSM-66 and Sensoril as separate products for precise dose control. Cost: $40–75/month for advanced stacks.

    Full adaptogen and recovery stack.

    • KSM-66 ashwagandha 300 mg BID + Sensoril 125 mg evening (adaptogen anchor)
    • Rhodiola rosea 300 mg morning (stimulating adaptogen, acute cognitive support)
    • Bacopa monnieri 300 mg/day (memory and cognitive support)
    • L-theanine 200 mg BID (acute calm and caffeine balance)
    • Magnesium glycinate 400 mg/day (split AM/PM)
    • Zinc 25 mg/day + vitamin D3 5000 IU/day + boron 5 mg/day (hormone cofactors)
    • Omega-3 (EPA+DHA) 2000 mg/day
    • Creatine 5 g/day
    • B-complex with methylated folate and B12
    • Vitamin E 400 IU/day (limit duration to 24 months)
    • CoQ10 100–200 mg/day
    • Optional: tongkat ali 200 mg/day (cycled 8 weeks on / 4 weeks off)
    • Optional: lion's mane 500 mg BID (cognitive)
    • Optional: berberine 500 mg BID (metabolic if indicated)

    Lifestyle integration (mandatory for advanced protocol benefit).

    • Sleep: 7–9 hours with strict sleep hygiene, environmental optimization (cool, dark, quiet), digital sunset 60+ minutes before bed, consistent timing.
    • Exercise: 3–4 strength training sessions + 2–3 moderate aerobic sessions + 1 high-intensity interval session per week (or adjusted per individual capacity and recovery).
    • Nutrition: Mediterranean dietary pattern with high-polyphenol EVOO (see oleocanthal and hydroxytyrosol), adequate protein (1.6–2.2 g/kg), vegetables at every meal, limited ultra-processed food, moderate or eliminated alcohol.
    • Recovery practices: 10+ minute daily mindfulness or meditation practice, sauna 2–4 times per week (for cardiovascular and stress-resilience benefits), cold exposure practice, 10,000+ steps/day baseline.
    • Social and mental stimulation: regular social connection, continued learning, purpose-driven activities.

    Cycling. Ashwagandha can be used continuously without meaningful tolerance development. Some practitioners recommend periodic breaks (e.g., 12 weeks on, 2–4 weeks off) to maintain responsiveness, though evidence of loss-of-effect over continuous use is absent. Rhodiola is more commonly cycled. Tongkat ali should be cycled (8 weeks on / 4 weeks off).

    Monitoring. Comprehensive metabolic panel (CMP), CBC, lipid panel, HbA1c, hsCRP, TSH, free T4, free T3, testosterone (total and free), SHBG, estradiol, DHEA-S, cortisol (morning), 25-OH vitamin D, homocysteine, ferritin — every 6 months. Liver enzymes specifically at 12 weeks after each dose change. BP at home weekly. Subjective tracking: sleep log, stress scale, energy, mood, libido, training recovery.

    Specific high-demand contexts.

    • Elite athletes: KSM-66 600 mg/day during heavy training blocks; add tongkat ali 200 mg/day during 8-week strength cycles. Adjust around competition (ashwagandha is generally permitted by anti-doping agencies but always check current banned lists). Recovery emphasis: sleep, nutrition, periodization of training load.
    • High-stress executives and founders: KSM-66 600 mg/day + l-theanine 200 mg as needed + rhodiola 300 mg morning for acute cognitive demand. Calendar discipline around recovery (workouts, sleep, unscheduled thinking time). Consider meditation or breathwork practice. Manage caffeine intake (stop by noon, cycle occasionally).
    • Perimenopausal and menopausal women: ashwagandha has supportive evidence for perimenopausal anxiety, sleep, and mood. 300–600 mg/day KSM-66 with attention to individual thyroid status. Combine with calcium + vitamin D + magnesium for bone support, omega-3, and discuss HRT options with gynecologist/internist.
    • Recovery from significant illness or surgery: KSM-66 300 mg BID can support recovery capacity alongside standard rehabilitation. Discuss with treating physician, particularly if immunosuppression is active.
    • Chronic fatigue or burnout patterns: combine ashwagandha with comprehensive evaluation (thyroid, adrenal, iron, B12, vitamin D, sleep assessment for apnea). Ashwagandha is supportive, not curative, for clinical chronic fatigue syndrome; appropriate medical evaluation is primary.

    Expected outcomes at 12+ months. Durable improvements in stress resilience, sleep quality, recovery from physical exertion, and subjective energy. Maintained or modestly improved testosterone in adult males. Maintained cognitive function with aging (preservation being realistic goal rather than enhancement). Reduced frequency of stress-related symptoms (tension headaches, GI disturbance, poor sleep following stressful days). Improved training adaptations in resistance-trained users.

    Exit criteria. Advanced protocol is designed for ongoing maintenance in users prioritizing longevity and optimized stress physiology. De-escalation to intermediate dose is appropriate if major life stressors resolve and lower-dose maintenance is sufficient. Continuous multi-year use at standard doses is well-supported by safety data.

    Commonly Stacked With

    Ashwagandha stacks naturally with other adaptogens, sleep and stress-management agents, and muscle/recovery supplements. The goal is mechanistic complementarity — hitting different nodes of the stress-sleep-recovery axis rather than duplicating the same mechanism.

    Tier 1: Stress-sleep foundation stack.

    • L-theanine 200 mg as needed or daily: acute GABA-A modulator and glutamate antagonist, produces relaxation without sedation. Complements ashwagandha's slower-onset HPA modulation. Particularly useful for acute stress moments, pre-sleep wind-down, or caffeine-balancing.
    • Magnesium glycinate 200–400 mg evening: NMDA antagonist and GABA-modulator, mineral cofactor for over 300 enzyme reactions, supports sleep and muscle relaxation. Highly complementary to ashwagandha; stack virtually universal in sleep-focused regimens.
    • Taurine 1–2 g evening: partial GABA-A agonist, cardiovascular support, mitigates stimulant anxiety. Optional addition for users on caffeine or pre-workout.
    • Glycine 3 g 30–60 min before bed: inhibitory neurotransmitter, improves deep sleep quality in several RCTs, mild core-temperature reduction aiding sleep onset.
    • GABA 500–1000 mg evening: limited BBB penetration but may have peripheral GABAergic effects; modestly effective for sleep onset in some users.

    Tier 2: Adaptogen rotation and synergy.

    • Rhodiola rosea 300–600 mg/day (standardized to 3% rosavins, 1% salidroside): stimulating adaptogen, dopaminergic/serotonergic, improves acute cognitive performance under fatigue. Use morning; ashwagandha evening. Rhodiola + ashwagandha is the "stimulating-calming adaptogen" stack — use rhodiola for focus and alertness, ashwagandha for recovery and sleep.
    • Bacopa monnieri 300 mg/day standardized to 50% bacosides: cognitive and memory-focused adaptogen with GABAergic and cholinergic effects. Slow-onset (4–12 weeks to full benefit). Stacks well with ashwagandha for cognitive concerns.
    • Gotu kola (Centella asiatica) 500 mg BID: circulatory, cognitive, and skin-health Ayurvedic companion to ashwagandha. Traditional stacking partner in Ayurvedic practice.
    • Panax ginseng or American ginseng (Panax quinquefolius): adaptogen with different mechanistic profile; can rotate with ashwagandha seasonally or stack in low doses.
    • Tulsi (Holy basil, Ocimum sanctum) 500 mg/day: Ayurvedic adaptogen with anti-inflammatory and mild anxiolytic effects. Complements ashwagandha.
    • Cordyceps 1–3 g/day: mushroom adaptogen with athletic and energy focus. Stacks for athletic applications.
    • Reishi (Ganoderma lucidum) 1–2 g/day: mushroom adaptogen with immune modulation and calming effects. Stacks for sleep and relaxation applications.

    Tier 3: Testosterone and athletic performance stack.

    • Tongkat ali (Eurycoma longifolia) 200–400 mg/day standardized extract: testosterone-supporting, particularly in aging or stressed males. Stacks well with ashwagandha for testosterone optimization. Cycle 8 weeks on / 2–4 weeks off.
    • Zinc 15–30 mg/day: essential for testosterone synthesis; deficiency limits ashwagandha's testosterone effect.
    • Vitamin D3 2000–5000 IU/day (per 25-OH level): essential for testosterone and multiple hormonal pathways.
    • Boron 3–10 mg/day: reduces SHBG, modestly elevating free testosterone.
    • Tribulus terrestris: traditional libido/performance herb; evidence for actual testosterone elevation is weak, but supportive for subjective vitality.
    • Creatine 5 g/day: strength and power support, complementary to ashwagandha in resistance training contexts.
    • Fenugreek extract 500 mg/day standardized: mild testosterone-supportive effect in some trials.
    • Omega-3 (EPA+DHA) 2000 mg/day: hormonal and anti-inflammatory support.

    Tier 4: Cognitive and aging brain stack.

    Tier 5: Metabolic and general-health stack.

    • Berberine 500 mg BID: insulin sensitization, complementary metabolic support.
    • Alpha-lipoic-acid 300–600 mg/day: mitochondrial antioxidant and insulin sensitizer.
    • CoQ10 100–200 mg/day: mitochondrial support.
    • Astaxanthin 4–12 mg/day: lipid-soluble antioxidant.

    Stacks to approach with caution.

    • High doses of multiple adaptogens simultaneously: "adaptogen overload" producing paradoxical fatigue, irritability, or blunted response. Rotate rather than stack-stack-stack.
    • Ashwagandha + sedating antihistamines, muscle relaxants, prescription sleep medications: additive sedation risk.
    • Ashwagandha + prescription testosterone replacement: TRT saturates the testosterone elevation effect; ashwagandha becomes superfluous for T levels but may still contribute to stress and sleep support.
    • Ashwagandha + multiple thyroid-active supplements (iodine, selenium, tyrosine, bladderwrack, coleus): synergistic thyroid effects, risk of iatrogenic hyperthyroidism; monitor TSH closely.
    • Ashwagandha + strong immunosuppressants (corticosteroids, methotrexate, biologics, calcineurin inhibitors): theoretical immune antagonism; discuss with prescribing specialist.

    Timing within stacks.

    • Morning: rhodiola, ginseng, bacopa (less sedating options), coffee and caffeine, B-complex.
    • Midday with food: ashwagandha first dose (if BID), berberine, curcumin, creatine.
    • Evening with food: ashwagandha main dose, magnesium glycinate, l-theanine, omega-3.
    • Pre-bed (30–60 min): glycine, taurine, additional magnesium, melatonin if needed.

    Monitoring on stacks. Baseline CBC, CMP, lipid panel, HbA1c, TSH, free T4, free T3, testosterone (total and free), SHBG, DHEA-S, morning cortisol, 25-OH vitamin D. Recheck relevant values after 8–12 weeks of regimen establishment. Track subjective measures: sleep quality (Pittsburgh Sleep Quality Index or simple sleep log), stress (Perceived Stress Scale), energy, mood, libido, training recovery.

    What NOT to stack with. High-dose stimulants (modafinil, amphetamines) paradoxically reduce ashwagandha's signature benefits by overwhelming HPA modulation with exogenous stimulation. Use one or the other; don't co-administer at high doses.

    Side Effects & Safety

    Ashwagandha is among the safest botanical extracts with extensive RCT data showing adverse event profiles comparable to placebo at standard doses. **Common (5–15% of users, typically mild and transient).** - *Mild sedation or drowsiness*: more pronounced at higher doses (600+ mg/day) and with evening dosing. Generally desired when targeting sleep; can be mitigated by morning-only dosing if undesired. - *Gastrointestinal*: mild nausea, epigastric discomfort, loose stools. Typically resolves by week 2. Take with food to reduce. - *Headache*: occasional mild headache in the first 1–2 weeks of use. Usually self-limited. **Uncommon (1–5% of users).** - *Vivid dreams*: a distinctive ashwagandha effect reported by some users, typically in the first 1–4 weeks. Not typically distressing; resolves with continued use or can be mitigated by earlier evening dosing. - *Mild reduction in libido or delayed ejaculation*: rare but reported; paradoxical given testosterone-elevating effects. Typically transient. - *Lightheadedness or mild hypotension*: in users with low-normal BP or on antihypertensives. **Rare (<1% of users).** - *Allergic reactions*: urticaria, rash, pruritus. Ashwagandha is in the Solanaceae family (alongside tomato, potato, eggplant, tobacco); users with Solanaceae-plant sensitivity may cross-react. - *Thyroid hyperfunction symptoms*: palpitations, heat intolerance, weight loss — important in users with baseline hyperthyroidism or over-replaced thyroid hormone therapy. - *Hepatotoxicity*: a very small number of case reports have associated ashwagandha with elevated liver enzymes or clinical hepatitis. Reviewed by LiverTox (NIH), which classifies ashwagandha as a rare cause of clinically apparent liver injury. The mechanism is unclear (possibly idiosyncratic, possibly contamination-related). Most case reports have involved high doses (>1000 mg/day) or non-standardized products; adulteration with other botanicals cannot always be excluded. This is a real but uncommon risk. **Special populations and considerations.** - *Autoimmune disease*: ashwagandha has immune-modulating effects that may theoretically exacerbate autoimmune conditions via immune stimulation. Clinical evidence of worsening is limited, but caution is warranted in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, Hashimoto's thyroiditis, and other autoimmune conditions. Discuss with rheumatologist or specialist before use; consider alternative adaptogens (rhodiola, l-theanine) if concerned. - *Hyperthyroidism / Graves' disease*: avoid. Ashwagandha elevates T3/T4 and can worsen hyperthyroid symptoms. - *Thyroid hormone replacement (levothyroxine)*: use with caution and thyroid monitoring. Ashwagandha may require levothyroxine dose reduction in over-replaced patients; however, in under-replaced patients it may supplement thyroid hormone levels. Coordinate with endocrinology. - *Pregnancy*: avoid. Classical Ayurvedic texts describe ashwagandha as abortifacient at high doses; modern data is limited but several case reports suggest risk of miscarriage. Definitively contraindicated in pregnancy. - *Lactation*: limited data. Avoid or discuss with pediatrician; evidence base insufficient to endorse routine use. - *Pediatric*: limited data in children. Some Ayurvedic pediatric use exists, but modern evidence and dose guidelines for children are lacking. Not recommended without pediatrician oversight. - *Elderly*: generally safe at standard doses. Start at lower end of dose range (300 mg/day) and titrate. Monitor BP and thyroid function. Be attentive to polypharmacy interactions. **Drug interactions — mostly mild, a few requiring attention.** - *Sedatives, benzodiazepines, alcohol*: additive sedation. Expect enhanced drowsiness; use caution when combining, particularly when driving or operating machinery. - *Thyroid hormone (levothyroxine, T3)*: ashwagandha's thyroid-hormone-elevating effect can push over-replaced patients into hyperthyroid range. Check TSH 6–8 weeks after initiating ashwagandha in patients on thyroid replacement; adjust levothyroxine downward if TSH suppresses below range. - *Antihypertensives*: ashwagandha has mild BP-lowering effect. Monitor BP during initiation; reduce antihypertensive dose if home BP drops below target. - *Antidiabetic medications*: mild additive glucose-lowering. Monitor glucose in patients on insulin, sulfonylureas, or meglitinides; clinically significant hypoglycemia is uncommon at standard ashwagandha doses. - *Immunosuppressants*: theoretical antagonism given immune-stimulating properties. Avoid in organ transplant recipients on tacrolimus, cyclosporine, or mycophenolate without transplant team consultation. - *Serotonergic medications (SSRIs, SNRIs, MAOIs)*: no clinically established interactions; the GABAergic and serotonergic modulation is mild. Discuss with prescribing clinician before adding to SSRI/SNRI regimens, particularly MAOIs (generic serotonin-precautions principle). - *Warfarin*: limited case reports of INR changes; monitor INR 2–3 weeks after addition. - *CYP450 effects*: generally weak; no clinically significant effects on CYP3A4, CYP2C9, or CYP2D6 metabolism at standard doses. **Stopping.** Ashwagandha does not cause withdrawal or rebound. Discontinuation is straightforward. Some users report the benefits (sleep quality, stress resilience) diminish over 1–2 weeks after stopping — this is reversal to baseline, not withdrawal. **Long-term safety.** Ashwagandha at standard doses has been used for millennia in Ayurvedic practice. Modern continuous-use data is limited to 6–12 month RCT extensions and observational follow-up, with no signal of cumulative toxicity, organ damage, or tolerance development. The rare hepatotoxicity case reports warrant attention but do not change the overall benign safety profile. Liver enzyme check 3 months after initiation and annually thereafter is a reasonable monitoring approach, particularly with doses >600 mg/day. **Product quality considerations.** - Branded standardized extracts (KSM-66, Sensoril, Shoden) have the strongest safety evidence. - Non-standardized bulk root powders have unclear potency and are more likely to be contaminated. - Ayurvedic products containing multiple herbs (especially imported "Ayurvedic" formulations) have historical concerns about heavy-metal contamination — stick to US-sold, third-party-tested products (USP, NSF, ConsumerLab). **Red flags warranting discontinuation.** - New yellow skin/eyes, dark urine, RUQ pain — possible hepatotoxicity; stop immediately and get liver enzymes. - New palpitations, heat intolerance, unexplained weight loss — possible thyroid hyperfunction; check TSH. - New autoimmune flare symptoms in users with known autoimmune disease. - Excessive sedation interfering with daytime function — reduce dose or switch to morning dosing. - Paradoxical worsening of anxiety or insomnia — individual variability; switch to alternative adaptogens.

    Contraindications

    Ashwagandha has a favorable overall safety profile with a small number of important contraindications and cautions. **Absolute contraindications.** - *Pregnancy*: avoid. Classical Ayurvedic texts describe ashwagandha as abortifacient at high doses; modern case reports suggest possible miscarriage risk. Definitively contraindicated throughout pregnancy. - *Hyperthyroidism and Graves' disease*: avoid. Ashwagandha elevates T3/T4 and suppresses TSH, worsening hyperthyroid symptoms. - *Thyroid hormone replacement with suppressed TSH*: avoid or use with close endocrinology coordination and TSH monitoring. Additional thyroid elevation can push over-replaced patients into iatrogenic hyperthyroidism. **Relative contraindications and cautions.** - *Autoimmune disease*: use with caution. Ashwagandha has immune-modulating effects that may theoretically exacerbate autoimmune conditions including lupus, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, Hashimoto's thyroiditis, Sjögren's, and others. Clinical evidence of worsening is limited, but sufficient concern exists to warrant discussion with rheumatologist or specialist before use. Consider alternative adaptogens (rhodiola, l-theanine, magnesium) if concerned. - *Lactation*: limited data; avoid or discuss with pediatrician. Classical Ayurvedic tradition includes some lactation use (as galactagogue); modern evidence insufficient to endorse. - *Pediatric use*: limited modern data. Not recommended for self-directed use in children; physician-supervised traditional use exists but is specialized. - *Organ transplant recipients on immunosuppression (tacrolimus, cyclosporine, mycophenolate)*: theoretical antagonism of immunosuppression given ashwagandha's immune-stimulating effects. Discuss with transplant team before use. - *Severe liver disease*: rare hepatotoxicity case reports. Consider avoiding at high doses (>600 mg/day); monitor liver enzymes more frequently if used. - *Concurrent sedating medications*: benzodiazepines, non-benzodiazepine hypnotics (zolpidem, eszopiclone, zaleplon), tricyclic antidepressants, antipsychotics, opioids, alcohol. Additive sedation. Start at low dose; use caution with driving and machinery operation. - *Low blood pressure or tendency to orthostatic hypotension*: ashwagandha has mild BP-lowering effect. Start at low dose; monitor for orthostatic symptoms. - *Bariatric surgery or gastric motility disorders*: standard capsule forms should be tolerated; powders may be better tolerated in users with restricted gastric capacity. - *Scheduled surgery*: discontinue ashwagandha 2 weeks before major surgery as generic precaution (addresses theoretical anesthesia interactions and any mild sedating carryover), though clinical evidence of surgical complications is lacking. **Drug interactions — mostly mild, a few requiring monitoring.** - *Thyroid hormones (levothyroxine, liothyronine)*: TSH may decrease in users on stable thyroid replacement due to ashwagandha's thyroid-elevating effect. Check TSH 6–8 weeks after starting ashwagandha. In over-replaced patients, reduce levothyroxine dose; in under-replaced patients, ashwagandha may serve as mild thyroid support. - *Sedatives (benzodiazepines, z-drugs, some tricyclics, opioids, alcohol)*: additive sedation. Adjust dosing and monitor for excessive drowsiness. - *Antihypertensives*: mild additive BP-lowering. Monitor home BP; reduce antihypertensive dose if below target. - *Antidiabetic medications*: mild additive glucose-lowering. Monitor glucose in insulin or sulfonylurea users; clinically significant hypoglycemia is uncommon. - *Immunosuppressants*: theoretical antagonism; avoid in transplant recipients. - *Anticoagulants (warfarin, DOACs)*: limited case reports of INR changes with warfarin; monitor INR 2–3 weeks after adding ashwagandha. DOACs: no specific monitoring required. - *Serotonergic medications (SSRIs, SNRIs, MAOIs)*: no established clinically significant interactions. Theoretical serotonergic interaction warrants caution with MAOIs specifically; start low and monitor. - *Testosterone replacement therapy*: no direct interaction; testosterone-elevating effect of ashwagandha is superfluous in users on adequate TRT but does not cause harm. Continue both; reassess need for ashwagandha-specific testosterone support. - *CYP450 interactions*: generally weak; no clinically significant interactions established at standard doses for CYP3A4, CYP2C9, CYP2D6 metabolism. **Hepatotoxicity — rare but real.** A small number of case reports have associated ashwagandha with elevated liver enzymes or clinical hepatitis. LiverTox (NIH) classifies ashwagandha as a rare cause of clinically apparent liver injury. Most reported cases involved high doses (>1000 mg/day) or non-standardized products; adulteration with other hepatotoxins cannot always be excluded. Safety framework: - Baseline liver enzymes (ALT, AST, ALP, bilirubin) before starting, particularly at doses >600 mg/day. - Recheck at 12 weeks if on higher doses. - New fatigue, jaundice, dark urine, right-upper-quadrant pain, unexplained nausea — stop ashwagandha and get liver enzymes. - Choose USP-verified, branded standardized extracts (KSM-66, Sensoril) to minimize adulteration risk. - Most users at standard doses (300–600 mg/day) of quality products have no liver concerns. **Contraindications that are NOT present.** - Normal thyroid function: not contraindicated. - Depression or anxiety without autoimmune disease: not contraindicated (often indicated as adjunct). - Cardiovascular disease: not contraindicated. - Hypertension on medications: generally beneficial; monitor for additive BP reduction. - Diabetes on standard medications: generally beneficial; monitor for additive glucose reduction. - Male hypogonadism or subfertility: indicated, not contraindicated. - Normal menstrual or perimenopausal hormonal variations: not contraindicated. - Aging generally: not contraindicated; often beneficial. - Cancer history without active treatment: generally acceptable; discuss with oncology if concerns. - Statin use, metformin use, SSRI use, most common chronic medications: compatible. **Red flags warranting discontinuation.** - Jaundice, dark urine, unexplained fatigue, right-upper-quadrant pain (possible hepatotoxicity). - New palpitations, heat intolerance, unexplained weight loss (possible iatrogenic hyperthyroidism). - Autoimmune flare symptoms in users with known autoimmune disease. - Excessive sedation interfering with function. - Paradoxical anxiety or insomnia (rare individual response). - Rash, urticaria, angioedema (allergy). **Not contraindicated but commonly confused.** - Ashwagandha is NOT the same as American ginseng (Panax quinquefolius), Korean ginseng (Panax ginseng), Siberian ginseng/eleuthero (Eleutherococcus senticosus), or Rhodiola rosea — all different adaptogens with different mechanisms. - Ashwagandha is NOT a substitute for prescription anxiolytic, sedative, or sleep medication. - Ashwagandha is NOT a substitute for testosterone replacement therapy in men with clinical hypogonadism. - Ashwagandha does NOT cure Alzheimer's, hyperthyroidism, or any serious medical condition. - "Organic" or "wild-harvested" claims do not guarantee higher potency; standardization is the quality indicator. **Summary.** Ashwagandha at standard doses of quality branded extracts (KSM-66, Sensoril) is among the safest and most broadly applicable supplements available. The small number of specific contraindications (pregnancy, hyperthyroidism, autoimmune disease caution) are readily identifiable. Drug interactions are mostly mild and manageable with awareness. For the majority of users — stressed, sleep-compromised, recovering from training, or pursuing general longevity goals — ashwagandha is a defensible daily-use adaptogen with strong RCT evidence and favorable risk profile.

    Check interactions with the Interaction Checker →

    Additional Notes

    Ashwagandha dosing is well-characterized across 30+ RCTs. The key variables are (1) extract standardization (total withanolide and withaferin A content), (2) brand and formulation, (3) dose, and (4) timing.

    Standard oral doses by indication.

    • General stress and daily adaptogen support: KSM-66 300–600 mg/day; Sensoril 125–250 mg/day; standardized 5% withanolide extract 300–600 mg/day.
    • Sleep support / non-clinical insomnia: ashwagandha root extract 600 mg/day as single evening dose (Langade 2019 PMID 31728244 dose); Sensoril 120–240 mg evening (Deshpande 2020 approach).
    • Anxiety and stress reduction: KSM-66 300 mg BID (Chandrasekhar 2012 PMID 23439798 dose); Sensoril 240 mg/day (Lopresti 2019 PMID 31517876 dose).
    • Testosterone optimization (aging or stressed males): KSM-66 600 mg/day (Lopresti 2019 Am J Mens Health PMID 30854916; Wankhede 2015 PMID 26609282).
    • Oligospermia / male infertility support: ashwagandha root extract ~675 mg/day for 90 days (Ambiye 2013 PMID 24371462).
    • Resistance training / strength and muscle gain: KSM-66 600 mg/day (Wankhede 2015 PMID 26609282).
    • Cognitive support: KSM-66 300 mg BID (Choudhary 2017).
    • Subclinical hypothyroidism with low T3/T4: ashwagandha root extract 600 mg/day for 8 weeks (Sharma 2018).

    Branded extract comparisons.

    • KSM-66 (Ixoreal Biomed): root-only, standardized to ≥5% withanolides with low withaferin A. Largest clinical evidence base. Dose: 300–600 mg/day (single dose or divided BID). Cost: moderate-to-premium.
    • Sensoril (Natreon): root + leaf, standardized to ≥10% withanolides with ~32% higher withaferin A. Faster onset for stress and sleep. Dose: 125–250 mg/day (usually single dose). Cost: moderate.
    • Shoden (Arjuna Natural): proprietary extract, standardized to ≥35% withanolide glycosides. Used in Lopresti 2019 trials. Dose: 120–240 mg/day.
    • Generic standardized extract (5% withanolides): variable quality. Dose range 300–600 mg/day. Lower cost; less certain potency.
    • Non-standardized root powder: avoid for therapeutic intent. Potency uncertain.

    Timing considerations.

    • Evening dosing (with dinner or 1–2 hours before bed): preferred for sleep-focused use; also good for general stress support. Leverages mild sedating effect to support sleep.
    • Morning dosing (with breakfast): fine if evening dosing causes any undesired sedation carryover. May produce subtle daytime calm without drowsiness in most users.
    • BID dosing (AM + PM): preferred for stress-focused or cognitive-support indications where sustained withanolide exposure is desired.
    • Pre-workout dosing: not the typical use case. Ashwagandha is better positioned as post-workout or evening recovery rather than pre-workout stimulation (where rhodiola or caffeine are more suitable).

    Dose titration.

    • Week 1: 300 mg once daily evening.
    • Week 2–4: if tolerated, increase to 300 mg BID if targeting stress/cognitive effects, or maintain 300 mg evening if targeting sleep alone.
    • Week 4+: if desired, escalate to 600 mg evening or 300 mg BID target.
    • For advanced protocol: 600 mg evening or 300 mg BID as steady dose, with optional addition of Sensoril for augmented spectrum.

    Duration and cycling.

    • Continuous use: supported by RCT extensions and observational data out to 6–12+ months without loss of benefit or safety signal.
    • Cycled use: some practitioners recommend 12 weeks on / 2–4 weeks off to maintain sensitivity. Evidence for necessity is limited but the practice is harmless.
    • Avoid: abrupt discontinuation is not harmful (no withdrawal), but the stress-buffering effect will reverse over 1–2 weeks — in users with highly stressful life circumstances, plan breaks for lower-stress periods.

    Ceiling dose. The highest ashwagandha doses in clinical trials have been ~1000 mg/day of standardized extract. Doses beyond this have not been shown to produce additional benefit and may increase risk of side effects including hepatotoxicity. There is no compelling rationale to exceed 1000 mg/day.

    Special populations.

    • Pediatric: ashwagandha has Ayurvedic pediatric use but limited modern data. Not recommended for self-directed use in children. Dose guidance for pediatric practice (weight-adjusted, under physician oversight) is 5–15 mg/kg/day for limited durations.
    • Elderly: start at lower dose (150–300 mg/day) and titrate. Monitor for drug interactions given polypharmacy. BP and thyroid function monitoring important.
    • Pregnancy: contraindicated. Classical texts and some case reports suggest abortifacient potential at high doses.
    • Lactation: limited data. Avoid or discuss with pediatrician.
    • Hepatic impairment: caution. Consider dose reduction and monitor liver enzymes more frequently given rare hepatotoxicity reports.
    • Renal impairment: no specific dose adjustment needed.
    • Hyperthyroidism: avoid — thyroid-elevating effect can worsen.
    • Autoimmune disease: caution; discuss with specialist.

    Cooking, teas, and traditional preparations. Ashwagandha root is used in Ayurvedic tradition as a decoction (boiled in water or milk, called "kshirapaka") or as churna (powder). Traditional doses are typically 1–3 g root powder twice daily, equivalent to a lower withanolide dose than standardized extracts at equivalent mg. For modern therapeutic intent, standardized extracts are preferable.

    Combination products. Many adaptogen blends include ashwagandha alongside rhodiola, eleuthero, holy basil, schisandra, and others. These can be convenient but typically underdose each ingredient. For evidence-based use, single-ingredient standardized products at RCT-validated doses are preferred. "Adrenal support" complexes often include ashwagandha; verify per-serving ashwagandha content before relying on them.

    Practical product selection. Brands using KSM-66 (check label): Jarrow Formulas Ashwagandha, NOW Foods Ashwagandha Extract, Life Extension Optimized Ashwagandha, Thorne Memoractiv, Designs for Health Insomnitol (adaptogen complex), Pure Encapsulations Ashwagandha, Source Naturals Ashwagandha, Gaia Herbs Ashwagandha Root, Himalaya Organic Ashwagandha (uses their own extract), Youtheory, and many others. For Sensoril products: Natreon-brand or Natreon-licensed products including various "stress formula" complexes. Avoid unspecified "Withania somnifera extract" without standardization percentage.

    Pricing. $15–30/month for a quality KSM-66 product at 600 mg/day; $25–50/month for an advanced multi-adaptogen stack. Ashwagandha is one of the best-value supplements in the adaptogen space given the strong evidence base and favorable cost.

    Frequently Asked Questions

    What is the recommended Ashwagandha dosage?

    Dosage for Ashwagandha varies by protocol. Consult a qualified healthcare provider.

    How often should I take Ashwagandha?

    Administration frequency depends on the specific protocol. Consult current research literature.

    Does Ashwagandha need to be cycled?

    Cycling requirements depend on the protocol. Follow established research guidelines.

    What are Ashwagandha side effects?

    Ashwagandha is among the safest botanical extracts with extensive RCT data showing adverse event profiles comparable to placebo at standard doses. **Common (5–15% of users, typically mild and transient).** - *Mild sedation or drowsiness*: more pronounced at higher doses (600+ mg/day) and with evening dosing. Generally desired when targeting sleep; can be mitigated by morning-only dosing if undesired. - *Gastrointestinal*: mild nausea, epigastric discomfort, loose stools. Typically resolves by week 2. Take with food to reduce. - *Headache*: occasional mild headache in the first 1–2 weeks of use. Usually self-limited. **Uncommon (1–5% of users).** - *Vivid dreams*: a distinctive ashwagandha effect reported by some users, typically in the first 1–4 weeks. Not typically distressing; resolves with continued use or can be mitigated by earlier evening dosing. - *Mild reduction in libido or delayed ejaculation*: rare but reported; paradoxical given testosterone-elevating effects. Typically transient. - *Lightheadedness or mild hypotension*: in users with low-normal BP or on antihypertensives. **Rare (<1% of users).** - *Allergic reactions*: urticaria, rash, pruritus. Ashwagandha is in the Solanaceae family (alongside tomato, potato, eggplant, tobacco); users with Solanaceae-plant sensitivity may cross-react. - *Thyroid hyperfunction symptoms*: palpitations, heat intolerance, weight loss — important in users with baseline hyperthyroidism or over-replaced thyroid hormone therapy. - *Hepatotoxicity*: a very small number of case reports have associated ashwagandha with elevated liver enzymes or clinical hepatitis. Reviewed by LiverTox (NIH), which classifies ashwagandha as a rare cause of clinically apparent liver injury. The mechanism is unclear (possibly idiosyncratic, possibly contamination-related). Most case reports have involved high doses (>1000 mg/day) or non-standardized products; adulteration with other botanicals cannot always be excluded. This is a real but uncommon risk. **Special populations and considerations.** - *Autoimmune disease*: ashwagandha has immune-modulating effects that may theoretically exacerbate autoimmune conditions via immune stimulation. Clinical evidence of worsening is limited, but caution is warranted in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, Hashimoto's thyroiditis, and other autoimmune conditions. Discuss with rheumatologist or specialist before use; consider alternative adaptogens (rhodiola, l-theanine) if concerned. - *Hyperthyroidism / Graves' disease*: avoid. Ashwagandha elevates T3/T4 and can worsen hyperthyroid symptoms. - *Thyroid hormone replacement (levothyroxine)*: use with caution and thyroid monitoring. Ashwagandha may require levothyroxine dose reduction in over-replaced patients; however, in under-replaced patients it may supplement thyroid hormone levels. Coordinate with endocrinology. - *Pregnancy*: avoid. Classical Ayurvedic texts describe ashwagandha as abortifacient at high doses; modern data is limited but several case reports suggest risk of miscarriage. Definitively contraindicated in pregnancy. - *Lactation*: limited data. Avoid or discuss with pediatrician; evidence base insufficient to endorse routine use. - *Pediatric*: limited data in children. Some Ayurvedic pediatric use exists, but modern evidence and dose guidelines for children are lacking. Not recommended without pediatrician oversight. - *Elderly*: generally safe at standard doses. Start at lower end of dose range (300 mg/day) and titrate. Monitor BP and thyroid function. Be attentive to polypharmacy interactions. **Drug interactions — mostly mild, a few requiring attention.** - *Sedatives, benzodiazepines, alcohol*: additive sedation. Expect enhanced drowsiness; use caution when combining, particularly when driving or operating machinery. - *Thyroid hormone (levothyroxine, T3)*: ashwagandha's thyroid-hormone-elevating effect can push over-replaced patients into hyperthyroid range. Check TSH 6–8 weeks after initiating ashwagandha in patients on thyroid replacement; adjust levothyroxine downward if TSH suppresses below range. - *Antihypertensives*: ashwagandha has mild BP-lowering effect. Monitor BP during initiation; reduce antihypertensive dose if home BP drops below target. - *Antidiabetic medications*: mild additive glucose-lowering. Monitor glucose in patients on insulin, sulfonylureas, or meglitinides; clinically significant hypoglycemia is uncommon at standard ashwagandha doses. - *Immunosuppressants*: theoretical antagonism given immune-stimulating properties. Avoid in organ transplant recipients on tacrolimus, cyclosporine, or mycophenolate without transplant team consultation. - *Serotonergic medications (SSRIs, SNRIs, MAOIs)*: no clinically established interactions; the GABAergic and serotonergic modulation is mild. Discuss with prescribing clinician before adding to SSRI/SNRI regimens, particularly MAOIs (generic serotonin-precautions principle). - *Warfarin*: limited case reports of INR changes; monitor INR 2–3 weeks after addition. - *CYP450 effects*: generally weak; no clinically significant effects on CYP3A4, CYP2C9, or CYP2D6 metabolism at standard doses. **Stopping.** Ashwagandha does not cause withdrawal or rebound. Discontinuation is straightforward. Some users report the benefits (sleep quality, stress resilience) diminish over 1–2 weeks after stopping — this is reversal to baseline, not withdrawal. **Long-term safety.** Ashwagandha at standard doses has been used for millennia in Ayurvedic practice. Modern continuous-use data is limited to 6–12 month RCT extensions and observational follow-up, with no signal of cumulative toxicity, organ damage, or tolerance development. The rare hepatotoxicity case reports warrant attention but do not change the overall benign safety profile. Liver enzyme check 3 months after initiation and annually thereafter is a reasonable monitoring approach, particularly with doses >600 mg/day. **Product quality considerations.** - Branded standardized extracts (KSM-66, Sensoril, Shoden) have the strongest safety evidence. - Non-standardized bulk root powders have unclear potency and are more likely to be contaminated. - Ayurvedic products containing multiple herbs (especially imported "Ayurvedic" formulations) have historical concerns about heavy-metal contamination — stick to US-sold, third-party-tested products (USP, NSF, ConsumerLab). **Red flags warranting discontinuation.** - New yellow skin/eyes, dark urine, RUQ pain — possible hepatotoxicity; stop immediately and get liver enzymes. - New palpitations, heat intolerance, unexplained weight loss — possible thyroid hyperfunction; check TSH. - New autoimmune flare symptoms in users with known autoimmune disease. - Excessive sedation interfering with daytime function — reduce dose or switch to morning dosing. - Paradoxical worsening of anxiety or insomnia — individual variability; switch to alternative adaptogens.

    Where can I buy Ashwagandha?

    Visit our vendor directory to find trusted sources for Ashwagandha.

    Free 2026 Peptide Cheat Sheet — 50 pages, PDF

    Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.

    Download Free
    ION-3R 18mg oral peptide drops bottle
    JUST RELEASED

    IonPeptide Drops

    New oral peptide stacks are now live. Explore trusted vendors on BodyHackGuide.

    COUPON CODEREDDIT
    View Drops →
    Research use only. Not for human consumption.|BodyHackGuide promotes vendors. We do not sell these products.